drugset / Trial / NCT00234533
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to establish an optimal monitoring regimen in NutropinAq treated children, using newly developed capillary blood spot IGF-1 measurement technology.
Timeline
- Start
- 2004-06
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.025 mg/kg | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | 0.035 mg/kg | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | 0.05 mg/kg | Subcutaneous |